Cargando…
PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review
Glioblastoma (GB) is a grade IV astrocytoma that maintains a poor prognosis with respect to current treatment options. Despite major advancements in the fields of surgery and chemoradiotherapy over the last few decades, the life expectancy for someone with glioblastoma remains virtually unchanged an...
Autores principales: | Fana, Michael, Gallien, John, Srinageshwar, Bhairavi, Dunbar, Gary L, Rossignol, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185330/ https://www.ncbi.nlm.nih.gov/pubmed/32368055 http://dx.doi.org/10.2147/IJN.S243155 |
Ejemplares similares
-
Current Therapeutic Strategies for Glioblastoma
por: Rossignol, Julien, et al.
Publicado: (2019) -
Curcumin Loaded Dendrimers Specifically Reduce Viability of Glioblastoma Cell Lines
por: Gallien, John, et al.
Publicado: (2021) -
Use of Polyamidoamine Dendrimers in Brain Diseases
por: Florendo, Maria, et al.
Publicado: (2018) -
A novel approach to label bone marrow-derived mesenchymal stem cells with mixed-surface PAMAM dendrimers
por: Munro, Nikolas, et al.
Publicado: (2019) -
PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice
por: Srinageshwar, Bhairavi, et al.
Publicado: (2017)